TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs
Orchestra BioMed Holdings Inc. (NASDAQ:OBIO) is one of the best biotech penny stocks to buy according to analysts.
Orchestra Biomed Holdings Inc. (OBIO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 5,037,906 | $21,411,101 | -2% | 0.42% |
| 2. | Alyeska Investment Group Anand Parekh | 1,000,000 | $4,250,000 | 0.01% | |
| 3. | Propel Bio Management Leen Kawas And Richard Kayne | 896,701 | $3,830,724 | 2.41% | |
| 4. | Millennium Management Israel Englander | 702,543 | $2,985,808 | +189% | 0% |
| 5. | Dorset Management David M. Knott | 253,651 | $1,078,017 | +2% | 0.64% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.83 | 5,000 | $19,150.00 | 1,064,029 | 2026-06-01 | Filing | |
| $3.75 | 665 | $2,493.75 | 118,118 | 2026-05-18 | Filing | |
| $3.90 | 8,971 | $34,986.90 | 117,453 | 2026-05-15 | Filing | |
| $3.77 | 5,000 | $18,850.00 | 1,059,029 | 2026-05-15 | Filing | |
| $4.13 | 20,000 | $82,600.00 | 91,709 | 2026-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.09 | 15,000 | $61,350.00 | 1,154,327 | 2026-08-03 | Filing | |
| $4.27 | 15,000 | $64,050.00 | 1,169,327 | 2026-07-01 | Filing | |
| $3.87 | 15,000 | $58,050.00 | 1,184,327 | 2026-06-01 | Filing | |
| $4.13 | 32 | $132.16 | 9,556,063 | 2026-04-27 | Filing | |
| $3.05 | 2,683 | $8,183.15 | 50,949 | 2025-06-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,510,387 | $10,832,320 | 0% | |
| 2. | 516,050 | $2,226,756 | 0% | |
| 3. | 424,000 | $1,829,560 | 0.09% | |
| 4. | 219,387 | $946,655 | 0.01% | |
| 5. | 89,608 | $386,659 | 0.01% |
News See All
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements
On November 12, 2025, The Fly reported that Barclays reduced its price target on Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) from $12 to $11, while maintaining an “Overweight” rating.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Billionaire Marc Lasry's Top 10 Stock Picks
In this piece, we will take a look at billionaire Marc Lasry's top ten stock picks.